As the world’s manufacturing hub, India has a $10 billion medtech market, but expanding enterprises in the space is still difficult. Experts blame obstacles like talent shortages, complicated regulations, and an undeveloped supply chain.
The absence of a strong local supply chain is one of the main problems, as was brought up during the annual health conference “Scale-Up Health 2024” this year. The scarcity of component suppliers affects Indian medtech companies, making it difficult for them to grow and compete on price.
India’s medical technology regulatory environment is still developing, creating a complicated and frequently changing scene. Businesses have to deal with several government organizations and make sure that different standards are followed, which may be expensive and time- consuming. India’s pharmaceutical regulatory landscape is well-established, but the country’s medtech regulations are still being developed, with the industry being involved in the development of these norms and more clarity being required.
There is a skill shortage in the medical technology sector, especially in research and development. Companies must make significant investments in internal training to upskill their staff because there aren’t enough specialized training programs or research centers. There have been some encouraging advancements, nevertheless. The creation of medical device parks and other government programs like the Production Linked Incentive (PLI) scheme are
intended to foster the expansion of the medtech industry.
The objectives of these programs are to draw foreign direct investment, support research and development, and improve infrastructure. It is anticipated that these steps will strengthen domestic manufacturing capacities and facilitate the faster scaling of medtech enterprises.
India has an opportunity as the global manufacturing landscape changes. Multinational corporations are anticipated to reap benefits from this realignment as they diversify their supply networks away from China.
The nation’s medtech industry can take advantage of this change to increase its production base and boost its standing on the international market. This potential is further supported by the growing acknowledgement of the medical device industry as a critical sector under the “Make in India” program.
Indian businesses are not only rising above obstacles, but also achieving progress. Traditional distribution and product development methods are being disrupted by innovations. In order to access a wider market, businesses are concentrating on creating high-quality, reasonably priced products and investigating innovative distribution strategies.
Notwithstanding the obstacles, Indian medical technology companies are in a strong position to take on global conglomerates by using their cost-effectiveness, technical know-how, and inventiveness. Given the ongoing growth and development of the sector, India has a good chance of becoming a major player in the global medtech landscape.